TAM
ONCY

Tocqueville Asset Management’s Oncolytics Biotech ONCY Stock Holding History

Tocqueville Asset Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Sell
147,000
-2,000
-1% -$1.85K ﹤0.01% 544
2026
Q1 		$126K Buy
149,000
+77,000
+107% +$76.6K ﹤0.01% 537
2025
Q4 		$62.9K Buy
+72,000
New +$77.8K ﹤0.01% 577

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Tocqueville Asset Management's ONCY Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Oncolytics Biotech (ONCY) stake by 1.3% in Q2 2026, selling an estimated $1.85K and leaving 147,000 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Tocqueville Asset Management first reported a position in ONCY in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Tocqueville Asset Management held 147,000 shares of Oncolytics Biotech worth $140K as of Q2 2026.
  • Tocqueville Asset Management sold 2,000 Oncolytics Biotech shares in Q2 2026, an estimated $1.85K.
  • Oncolytics Biotech made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q2 2026, its #544 holding.
  • Tocqueville Asset Management first reported a position in Oncolytics Biotech in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.